Staphylococcus epidermidis modulates EMT-related gene expression and viability in MDA-MB-231 breast cancer cells

Breast tissue microbiota differs between healthy and cancerous tissues, with some bacteria influencing tumor progression. Staphylococcus epidermidis, a common skin commensal found in breast tumors, may play a role in epithelial-mesenchymal transition (EMT), a key step in metastasis. This study evaluated the effects of S. epidermidis culture and cell-free supernatant (CFS) on MDA-MB-231 breast cancer cell survival and expression of EMT-related genes Snail1, fibronectin 1 (FN1), and N-cadherin (CDH2).

Different concentrations of S. epidermidis cultures and their CFS were applied to MDA-MB-231 cells. Cytotoxic effects were assessed by MTT assay at 2, 4, and 24 hours post-treatment. Real-time PCR analyzed gene expression after 24 hours of exposure to non-toxic concentrations (MOI 50 and 100 for cultures; 14% for CFS).

Low concentrations did not affect viability, while higher doses (MOI 100 and 14% CFS) reduced viability by up to 60% and 90%, respectively, at 24 hours. MOI 50 did not significantly alter gene expression. At MOI 100, Snail1 and FN1 were significantly upregulated, but CDH2 was unchanged. Treatment with 5% and 7% CFS significantly increased all three EMT gene expressions, indicating EMT induction.

S. epidermidis affects EMT gene expression and cell viability, indicating potential involvement in breast cancer progression.